Report cover image

Urology - Market - Report - Suite - Europe - 2022-2028 - MedSuite

Publisher iData Research, Inc.
Published Feb 23, 2022
Length 602 Pages
SKU # IDR17686857

Description

Urology - Market - Report - Suite - Europe - 2022-2028 - MedSuite

Overall, Europe’s urological device market was valued at €1.7 billion in 2021. This was a 10% decrease from the 2020 market value with the global COVID-19 pandemic having an impact on the market. However, this is expected to increase over the forecasted period at a CAGR of 2.6% to reach €2.1 billion by 2028.

Currently, the strongest competitors within Europe’s urological device market are Coloplast and Wellspect Healthcare alongside other market leaders such as Becton Dickinson, Hollister Inc. and Boston Scientific.

Throughout this medical market research, we analyzed over 60 urological device companies in Europe and around the world using our comprehensive methodology to understand the market sizes, unit sales, company market shares, procedure volumes, and to create accurate forecasts.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
EUROPE UROLOGICAL DEVICE MARKET INSIGHTS
Urological devices

Overall, the urological device market is strongly established. This limits the potential for substantial growth. Although companies continue to provide novel adaptations for their products, the general trend within most segments of the market is a fairly flat ASP. Furthermore, the ASP has been limited by the lack of reimbursement in some countries along with price pressures witnessed across Europe.

EUROPE UROLOGICAL DEVICE MARKET SHARE INSIGHTS

The European urological device market was controlled by Coloplast and Wellspect Healthcare. In 2021, the leading competitor in the urological device market was Coloplast. The company held the top position in the urinary catheter, urinary guidewire and erectile dysfunction device segments. It also played a substantial role in the stone management device, nephrostomy device and urinary incontinence device segments.

MARKET SEGMENTATION SUMMARY

Urinary Catheter Market – Further Segmented Into:
Intermittent, Foley, male external catheters (MECs) and female external catheters (FECs).
Urinary Incontinence Device Market – Further Segmented Into:
UBAs and incontinence slings.
BPH Treatment Device Market — Further Segmented Into:
Devices used for transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rez?m® procedures.
Urological Endoscope Market — Further Segmented Into:
Single-use, rigid and flexible cystoscopes, single-use, semi-rigid and flexible ureteroscopes, rigid resectoscopes and rigid nephroscopes.
Low-Dose Radiation Brachy Therapy Device Market — Further Segmented Into:
LDR seeds.
Nephrostemy Market — Further Segmented Into:
Percutaneous nephrostomy sets, nephrostomy balloon dilators and nephrostomy drainage tubes.
Erectile Dysfunction Device Market — Further Segmented Into:
Inflatable erectile dysfunction devices and malleable erectile dysfunction devices.
Urinary Guidewire Market — Further Segmented Into:
All guidewires to be used in urological procedures.
Stone Management Device Market – Further Segmented Into:
ESWL capital equipment, laser equipment, stone fragment retrieval devices, ureteral stents and access sheaths.

RESEARCH SCOPE SUMMARY

Region: Europe
Base Year: 2021
Forecast: 2022 – 2028
Historical Data: 2018 – 2021
Quantitative Coverage: Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices
Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. WHY CHOOSE iDATA?
Experts Only – iData has been around for over 16 years and is the trusted source of intelligent, data-driven insights by key industry players. We are comprised of specialists with a sole focus on medical and dental devices. Our research and consulting focus never strays from the medical device industry and, because of this, we know the industry like the back of our hands.

Attention to Details - It’s our attention to the small stuff, scheduling of timelines and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - Our prices are competitive and fair. We strive for success and want our clients to as well, with the level of detail our reports achieve along with the extensive segmentation, no other reports compare at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.

The full report suite on the European Urological Devices Market includes coverage on the Urinary Catheter Market, Urinary Incontinence Device Market, BPH Treatment Device Market, Urological Endoscope Makret, Low-Dose Radiation Brachy Therapy Device Market, Nephrostemy Market, Erectile Dysfunction Device Market, Urinary Guidewire Market, and Stone Management Device Market.

Table of Contents

602 Pages
EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
IMPACT OF COVID-19 ON THE EUROPEAN UROLOGICAL DEVICE MARKET
2.1 INTRODUCTION
2.2 COUNTRY PROFILES
2.3 ANALYSIS BY MARKET SEGMENT
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
DISEASE OVERVIEW
3.1 BASIC ANATOMY
3.1.1 Urinary System
3.1.1.1 Male Urinary System
3.1.1.2 Female Urinary System
3.2 DISEASE TREATMENT AND DIAGNOSTICS
3.2.1 Benign Prostatic Hyperplasia
3.2.2 Urinary Incontinence
3.2.3 Urinary Tract Infections
3.2.4 Kidney Stones
3.2.5 Bladder Prolapse
3.2.6 Overactive Bladder
3.2.7 Prostatitis
3.2.8 Men’s Reproductive Health
3.2.9 Cancer
3.2.9.1 Prostate Cancer
3.2.9.2 Bladder Cancer
3.3 PATIENT DEMOGRAPHICS
3.3.1 Benign Prostatic Hyperplasia
3.3.2 Urinary Incontinence
3.3.3 Urinary Tract Infections
3.3.4 Kidney Stones
3.3.5 Bladder Prolapse
3.3.6 Overactive Bladder
3.3.7 Prostatitis
3.3.8 Men’s Reproductive Health
3.3.9 Cancer
3.3.9.1 Prostate Cancer
3.3.9.2 Bladder Cancer
PRODUCT ASSESSMENT
4.1 INTRODUCTION
4.2 PRODUCT PORTFOLIOS
4.2.1 Urinary Incontinence
4.2.1.1 Urinary Catheters
4.2.1.1.1 Intermittent Catheters
4.2.1.1.2 Foley Catheters
4.2.1.1.3 Male External Catheters
4.2.1.1.4 Female External Catheters
4.2.1.2 Urethral Bulking Agents
4.2.1.3 Incontinence Management Devices
4.2.1.3.1 Female Incontinence Slings
4.2.1.3.2 Male Implantable Devices
4.2.1.4 Urine Bags
4.2.1.4.1 Leg Bags
4.2.1.4.2 Bedside Drainage Bags
4.2.2 Stone Management
4.2.2.1 ESWL Equipment
4.2.2.2 Intracorporeal Lithotripsy Equipment
4.2.2.3 Holmium Lasers
4.2.2.4 Stone Fragment Retrieval Devices
4.2.2.5 Ureteral Stents
4.2.2.6 Thulium Lasers and Fibers
4.2.2.7 Holmium Fibers
4.2.3 BPH Treatment
4.2.3.1 TURP
4.2.3.2 TUMT
4.2.3.3 TUNA
4.2.3.4 Prostatic Stents
4.2.3.5 Novel BPH Solutions
4.2.3.5.1 Rezum™
4.2.3.5.2 UroLift®
4.2.3.5.3 iTind
4.2.3.6 Laser BPH
4.2.3.6.1 Photoselective Vaporization of the Prostate (PVP)
4.2.3.6.2 Laser Vaporization of the Prostate
4.2.3.6.3 Laser Ablation of the Prostate
4.2.3.6.4 Laser Resection of the Prostate
4.2.3.6.5 Laser Enucleation of the Prostate
4.2.4 Urological Endoscopes
4.2.4.1 Cystoscopes
4.2.4.2 Ureteroscopes
4.2.4.3 Resectocopes
4.2.4.4 Nephroscopes
4.2.5 Prostate Cancer Treatment
4.2.5.1 Brachytherapy
4.2.5.1.1 Permanent Implants
4.2.5.1.2 Temporary Implants
4.2.5.1.3 Cryotherapy
4.2.6 Urodynamics
4.2.6.1 Urodynamic Equipment
4.2.6.2 Urodynamic Consumables
4.2.6.2.1 Water-Charged Catheters
4.2.6.2.2 Air-Charged Catheters
4.2.6.2.3 Fiber-Optic Catheters
4.2.7 Nephrostomy
4.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets
4.2.7.2 Nephrostomy Balloon Catheters
4.2.7.3 Ureteral Stents
4.2.8 Men’s Reproductive Health
4.2.8.1 Penile Implants
4.2.8.1.1 Inflatable
4.2.8.1.2 Malleable
4.2.8.2 Vacuum
4.2.8.3 Testicular Implants
4.2.9 Urinary Guidewires
4.3 REGULATORY ISSUES AND RECALLS
4.3.1 Becton Dickinson
4.3.1.1 Urinary Incontinence Device
4.3.2 Boston Scientific
4.3.2.1 Urinary Incontinence Device
4.3.2.2 Stone Management Device
4.3.2.3 BPH Treatment Device
4.3.2.4 Prostate Cancer Treatment Device
4.3.3 Coloplast
4.3.3.1 Men’s Reproductive Health Device
4.3.4 Dornier MedTech
4.3.4.1 BPH Treatment Device
4.3.5 Galil Medical
4.3.5.1 Prostate Cancer Treatment Device
4.3.6 Olympus
4.3.6.1 Urological Endoscope
4.3.7 Teleflex
4.3.7.1 Urinary Incontinence Device
4.4 CLINICAL TRIALS
4.4.1 Boston Scientific
4.4.1.1 Urinary Incontinence Device
4.4.1.2 Stone Management Device
4.4.1.3 BPH Treatment
4.4.1.4 Urological Endoscope
4.4.2 Coloplast
4.4.2.1 Urinary Incontinence Device
4.4.3 LABORIE
4.4.3.1 Urinary Incontinence Device
4.4.3.2 Urodynamic Equipment
4.4.4 Teleflex
4.4.5 Other
4.4.5.1 Urinary Incontinence Device
4.4.5.2 Stone Management Device
4.4.5.3 Urological Endoscope
4.4.5.4 Prostate Cancer Treatment Device
4.4.5.5 Urodynamic Equipment
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
5.1 CURRENCY EXCHANGE RATE
5.2 MARKET OVERVIEW & TREND ANALYSIS
5.3 DRIVERS AND LIMITERS
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 COMPETITIVE MARKET SHARE ANALYSIS
5.5 MERGERS AND ACQUISITIONS
5.6 COMPANY PROFILES
5.6.1 Becton Dickinson
5.6.2 Boston Scientific
5.6.3 Cardinal Health
5.6.3.1 Cordis (Cardinal Health)
5.6.4 Coloplast
5.6.5 Cook Medical
5.6.6 Elekta
5.6.7 Karl Storz
5.6.8 LABORIE
5.6.9 Olympus
5.6.10 Teleflex
5.7 SWOT ANALYSIS
5.7.1 Becton Dickinson
5.7.2 Boston Scientific
5.7.3 Cardinal Health
5.7.4 Coloplast
5.7.5 Cook Medical
5.7.6 Elekta
5.7.7 Karl Storz
5.7.8 LABORIE
5.7.9 Lumenis
5.7.10 Olympus
5.7.11 Teleflex
COUNTRY PROFILES
6.1 INTRODUCTION
6.1.1 Population
6.1.2 GDP Per Capita
6.1.3 Price Index
6.2 GERMANY
6.3 FRANCE
6.4 UNITED KINGDOM
6.5 ITALY
6.6 SPAIN
6.7 BENELUX
6.8 SCANDINAVIA
6.9 AUSTRIA
6.10 SWITZERLAND
6.11 PORTUGAL
PROCEDURE NUMBERS
7.1 PROCEDURE OVERVIEW
7.2 PROSTATE CANCER TREATMENT PROCEDURES
7.2.1 Open and Laparoscopic Prostatectomy Procedures
7.2.2 Robotic Prostatectomy Procedures
7.2.3 Watchful Waiting Procedures
7.2.4 HIFU Procedures
7.2.5 Brachytherapy Procedures
7.2.6 High Dose Radiation Procedures
7.2.7 External Radiation Therapy (Primary) Procedures
7.2.8 External Radiation Therapy (Secondary) Procedures
7.3 INTERVENTIONAL BPH PROCEDURES
7.3.1 TURP Procedures
7.3.2 Laser BPH Procedures
7.4 STONE MANAGEMENT PROCEDURES
7.4.1 ESWL Procedures
7.4.2 Stone Management Holmium Laser Procedures
7.4.3 PCNL Procedures
7.4.4 Ureteral Stent Placement Procedures
7.5 NEPHROSTOMY PROCEDURES
7.6 URINARY INCONTINENCE PROCEDURES
7.6.1 Male Urinary Incontinence Procedures
7.6.2 Female Urinary Incontinence Procedures
7.7 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES
URINARY CATHETER MARKET
8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Urinary Catheter Market
8.3.2 Intermittent Urinary Catheter Market
8.3.3 Foley Catheter Market
8.3.4 External Catheter Market
8.3.4.1 Male External Catheter Market
8.3.4.2 Female External Catheter Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS
URINARY INCONTINENCE DEVICE MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Urethral Bulking Agent Market
9.3.2 Urinary Incontinence Sling Market
9.3.2.1 Female Incontinence Sling Market
9.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market
9.3.2.1.2 Transobturator Female Incontinence Sling Market
9.3.2.1.3 Single-Incision Female Incontinence Sling Market
9.3.2.2 Male Incontinence Sling Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
STONE MANAGEMENT DEVICE MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 ESWL Equipment Market
10.3.2 Stone Management Laser Market
10.3.2.1 Holmium Stone Management Laser Market
10.3.2.1.1 Holmium Stone Management Laser Capital Equipment Market
10.3.2.1.2 Holmium Stone Management Laser Fiber Market
10.3.2.2 Thulium Stone Management Laser Market
10.3.2.2.1 Thulium Stone Management Laser Capital Equipment Market
10.3.2.2.2 Thulium Stone Management Laser Fiber Market
10.3.3 Stone Fragment Retrieval Device Market
10.3.3.1 Nitinol Stone Fragment Retrieval Device Market
10.3.3.1.1 Nitinol Basket Stone Fragment Retrieval Device Market
10.3.3.1.2 Nitinol Grasper Stone Fragment Retrieval Device Market
10.3.3.2 Stainless Steel Stone Fragment Retrieval Device Market
10.3.3.2.1 Stainless Steel Basket Stone Fragment Retrieval Device Market
10.3.3.2.2 Stainless Steel Grasper Stone Fragment Retrieval Device Market
10.3.4 Ureteral Stent Market
10.3.5 Access Sheath Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
BPH TREATMENT DEVICE MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 TURP Market
11.3.1.1 Monopolar Electrode Market
11.3.1.2 Bipolar Electrode Market
11.3.2 Laser BPH Market
11.3.2.1 Holmium Laser BPH Market
11.3.2.1.1 Holmium Laser BPH Capital Equipment Market
11.3.2.1.2 Holmium Laser BPH Fiber Market
11.3.2.2 Thulium Laser BPH Market
11.3.2.2.1 Thulium Laser BPH Capital Equipment Market
11.3.2.2.2 Thulium Laser BPH Fiber Market
11.3.3 UroLift Market
11.3.4 Rezūm Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
UROLOGICAL ENDOSCOPE MARKET
12.1 INTRODUCTION
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Total Urological Endoscope Market
12.3.2 Cystoscope Market
12.3.2.1 Single-Use Cystoscope Market
12.3.2.2 Rigid Cystoscope Market
12.3.2.3 Flexible Cystoscope Market
12.3.2.3.1 Flexible Fiber Optic Cystoscope Market
12.3.2.3.2 Flexible Video Cystoscope Market
12.3.3 Ureteroscope Market
12.3.3.1 Single-Use Ureteroscope Market
12.3.3.2 Semi-Rigid Ureteroscope Market
12.3.3.3 Flexible Ureteroscope Market
12.3.3.3.1 Flexible Fiber Optic Ureteroscope Market
12.3.3.3.2 Flexible Video Ureteroscope Market
12.3.4 Resectoscope Market
12.3.5 Nephroscope Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
LOW DOSE RADIATION BRACHYTHERAPY DEVICE MARKET
13.1 INTRODUCTION
13.2 MARKET ANALYSIS AND FORECAST
13.3 DRIVERS AND LIMITERS
13.3.1 Market Drivers
13.3.2 Market Limiters
13.4 COMPETITIVE MARKET SHARE ANALYSIS
NEPHROSTOMY DEVICE MARKET
14.1 INTRODUCTION
14.2 MARKET OVERVIEW
14.3 MARKET ANALYSIS AND FORECAST
14.3.1 Percutaneous Nephrostomy Set Market
14.3.2 Nephrostomy Balloon Catheter Market
14.3.3 Nephrostomy Drainage Tube Market
14.4 DRIVERS AND LIMITERS
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 COMPETITIVE MARKET SHARE ANALYSIS
ERECTILE DYSFUNCTION DEVICE MARKET
15.1 INTRODUCTION
15.2 MARKET OVERVIEW
15.3 MARKET ANALYSIS AND FORECAST
15.3.1 Total Erectile Dysfunction Device Market
15.3.2 Inflatable Erectile Dysfunction Device Market
15.3.3 Malleable Erectile Dysfunction Device Market
15.4 DRIVERS AND LIMITERS
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 COMPETITIVE MARKET SHARE ANALYSIS
URINARY GUIDEWIRE MARKET
16.1 INTRODUCTION
16.2 MARKET ANALYSIS AND FORECAST
16.3 DRIVERS AND LIMITERS
16.3.1 Market Drivers
16.3.2 Market Limiters
16.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
LIST OF CHARTS
Chart 1 1: Urological Device Market by Segment, Europe, 2021 – 2028
Chart 1 2: Urological Device Market Overview, Europe, 2021 & 2028
Chart 2 1: Multi-Scenario Urological Device Market Forecast, Europe, 2018 – 2028 (€M)
Chart 5 1: Urological Device Market by Segment, Europe, 2018 – 2028
Chart 5 2: Leading Competitors, Urological Device Market, Europe, 2021
Chart 6 1: Country Profile, Germany, 2021
Chart 6 2: Country Profile, France, 2021
Chart 6 3: Country Profile, United Kingdom, 2021
Chart 6 4: Country Profile, Italy, 2021
Chart 6 5: Country Profile, Spain, 2021
Chart 6 6: Country Profile, Benelux, 2021
Chart 6 7: Country Profile, Scandinavia, 2021
Chart 6 8: Country Profile, Austria, 2021
Chart 6 9: Country Profile, Switzerland, 2021
Chart 6 10: Country Profile, Portugal, 2021
Chart 7 1: Urological Procedures by Segment, Europe, 2018 – 2028
Chart 8 1: Leading Competitors, Urinary Catheter Market, Europe, 2021
Chart 9 1: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028
Chart 9 2: Leading Competitors, Urinary Incontinence Device Market, Europe, 2021
Chart 10 1: Stone Management Device Market by Segment, Europe, 2018 – 2028
Chart 10 2: Leading Competitors, Stone Management Device Market, Europe, 2021
Chart 11 1: BPH Treatment Device Market by Segment, Europe, 2018 – 2028
Chart 11 2: Leading Competitors, BPH Treatment Device Market, Europe, 2021
Chart 12 1: Urological Endoscope Market by Segment, Europe, 2018 – 2028
Chart 12 2: Leading Competitors, Urological Endoscope Market, Europe, 2021
Chart 13 1: LDR Brachytherapy Market, Europe, 2018 – 2028
Chart 13 2: Leading Competitors, Lose Dose Radiation Brachytherapy Device Market, Europe, 2021
Chart 14 1: Nephrostomy Device Market by Segment, Europe, 2018 – 2028
Chart 14 2: Leading Competitors, Nephrostomy Device Market, Europe, 2021
Chart 15 1: Erectile Dysfunction Device Market by Segment, Europe, 2018 – 2028
Chart 15 2: Leading Competitors, Erectile Dysfunction Device Market, Europe, 2021
Chart 16 1: Urinary Guidewire Market, Europe, 2018 – 2028
Chart 16 2: Leading Competitors, Urinary Guidewire Market, Europe, 2021
List of Figures
Figure 1-1: Urological Device Market Share Ranking by Segment, Europe, 2021 (1 of 2) 4
Figure 1-2: Urological Device Market Share Ranking by Segment, Europe, 2021 (2 of 2) 5
Figure 1-3: Companies Researched in this Report (1 of 2) 6
Figure 1-4: Companies Researched in this Report (2 of 2) 7
Figure 1-5: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2) 8
Figure 1-6: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2) 9
Figure 1-7: Recent Events in the Urological Device Market, Europe, 2018 – 2022 10
Figure 1-8: Urological Device Procedures Covered, Europe 11
Figure 1-9: Urological Device Markets Covered, Europe (1 of 2) 12
Figure 1-10: Urological Device Markets Covered, Europe (2 of 2) 13
Figure 1-11: Key Report Updates 14
Figure 1-12: Version History 14
Figure 2-1: Urological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 36
Figure 2-2: Urological Device Market by Segment, Worst Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 37
Figure 2-3: Urological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 38
Figure 2-4: Urological Device Market by Segment, Base Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 39
Figure 2-5: Urological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (1 of 2) 40
Figure 2- 6: Urological Device Market by Segment, Best Case Scenario, Europe, 2018 – 2028 (€M) (2 of 2) 41
Figure 4-1: Urinary Incontinence Treatments by Company (1 of 3) 75
Figure 4-2: Urinary Incontinence Treatments by Company (2 of 3) 76
Figure 4-3: Urinary Incontinence Treatments by Company (3 of 3) 77
Figure 4-4: Stone Management Devices by Company (1 of 3) 82
Figure 4-5: Stone Management Devices by Company (2 of 3) 83
Figure 4-6: Stone Management Devices by Company (3 of 3) 84
Figure 4-7: BPH Treatments by Company 94
Figure 4-8: Urological Endoscopes by Company (1 of 2) 98
Figure 4-9: Urological Endoscopes by Company (2 of 2) 99
Figure 4-10: Prostate Cancer Treatments by Company 103
Figure 4-11: Urodynamic Equipment and Consumables by Company 107
Figure 4-12: Nephrostomy Devices by Company 110
Figure 4-13: Men’s Reproductive Health Devices by Company 113
Figure 4-14: Testicular Implants by Company 114
Figure 4-15: Urinary Guidewires by Company 115
Figure 4-16: Class 2 Device Recall Magic 3 Intermittent Catheters 116
Figure 4-17: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 116
Figure 4-18: Class 2 Device Recall Bard Magic 3 Antibacterial Hydrophilic Intermittent Catheter 116
Figure 4-19: Class 2 Device Recall SureStep 117
Figure 4-20: Class 2 Device Recall AMS 800 Artificial Urinary Sphincter AMS 800 Belt Cuff 117
Figure 4-21: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone 117
Figure 4-22: Class 2 Device Recall Uphold LITE w/ Capio SLIM 118
Figure 4-23: Class 2 Device Recall Stretch VL Ureteral Stent Set 118
Figure 4-24: Class 2 Device Recall Contour VL Ureteral Stent Set 118
Figure 4-25: Class 2 Device Recall Auriga 30 Laser System 119
Figure 4-26: Class 2 Device Recall AURIGA 30 BRAZIL ZERO COST SYSTEM 119
Figure 4-27: Class 2 Device Recall MoXy Laser Fiber 119
Figure 4-28: Class 2 Device Recall IcePearl 2.1 CX 90 Cyroablation Needles 120
Figure 4-29: Class 2 Device Recall IceSphere Cryoablation Needles 120
Figure 4-30: Class 2 Device Recall Titan Pump 121
Figure 4-31: Class 2 Device Recall Dornier 121
Figure 4-32: Class 2 Device Recall Visual ICE Cryoablation System 122
Figure 4-33: Class 2 Device Recall Ureteroreno videoscope URFV2; Ureteroreno videoscope URFV2R 123
Figure 4-34: Class 3 Device Recall RUSCH Urinary Drainage bag 123
Figure 4-35: Class 2 Device Recall Rusch EasyCath Kit 124
Figure 4-36: Class 3 Device Recall Teleflex MEDICAL RuSCH One piece Male External Medium Catheter W/O Tape 124
Figure 4-37: Artificial Urinary Sphincter Clinical Outcomes (AUSCO) 125
Figure 4-38: Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy (SASS) 125
Figure 4-39: Double-J PLUS Postmarket Registry 126
Figure 4-40: Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot) 126
Figure 4-41: Rezum FIM Optimization Study (Rezum FIM) 127
Figure 4-42: To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China 127
Figure 4-43: To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease (LithoVue) 128
Figure 4-44: Investigation of New Intermittent Catheters in Healthy Volunteers 128
Figure 4-45: Exploratory Study of a New Urine Collection Device for Men 129
Figure 4-46: Investigation of Non-CE Marked Intermittent Catheters for Females 129
Figure 4-47: T-DOC® 5 Fr Pediatric Clinical Investigation 130
Figure 4-48: T-DOC® NXT Clinical Investigation 130
Figure 4-49: e۰Sense® Catheter Clinical Investigation 131
Figure 4-50: T-DOC® 5 Fr Pediatric Clinical Investigation 131
Figure 4-51: Study of Median Lobe Prostatic UroLift Procedure 132
Figure 4-52: Urodynamic Feasibility Study Utilizing the UroLift® System (UDS) 132
Figure 4-53: Comparing UroLift Experience Against Rezūm (CLEAR) 133
Figure 4-54: ARTUS MONO Artificial Urinary Sphincter 133
Figure 4-55: Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence (PROSPECT) 134
Figure 4-56: Connected Catheter- Safety and Effectiveness Study 134
Figure 4-57: Evaluation of a New Female Urinary Intermittent Catheter 135
Figure 4-58: Post-Market Clinical Follow-Up onTVT EXACT® Continence System 135
Figure 4-59: A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care. 136
Figure 4-60: Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy (URIPRENE) 136
Figure 4-61: The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position 137
Figure 4-62: Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder 137
Figure 4-63: Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy 138
Figure 4-64: LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono) 138
Figure 4-65: Urodynamic Assessment of the Lower Urinary Tract: Water vs. Air - Synchrony 139
Figure 5-1: Currency Exchange Rate, 2021 140
Figure 5-2: Urological Device Market by Segment, Europe, 2018 – 2028 (€M) (1 of 2) 143
Figure 5-3: Urological Device Market by Segment, Europe, 2018 – 2028 (€M) (2 of 2) 144
Figure 5-4: Urological Device Market by Segment, Europe, 2018 – 2028 (US$M) (1 of 2) 145
Figure 5-5: Urological Device Market by Segment, Europe, 2018 – 2028 (US$M) (2 of 2) 146
Figure 5-6: Leading Competitors, Urological Device Market, Europe, 2021 (1 of 2) 155
Figure 5-7: Leading Competitors, Urological Device Market, Europe, 2021 (1 of 2) 156
Figure 5-8: Others Include: 157
Figure 5-9: SWOT Analysis, Becton Dickinson 174
Figure 5-10: SWOT Analysis, Boston Scientific 175
Figure 5-11: SWOT Analysis, Cardinal Health 176
Figure 5-12: SWOT Analysis, Coloplast 177
Figure 5-13: SWOT Analysis, Cook Medical 178
Figure 5-14: SWOT Analysis, Elekta 179
Figure 5-15: SWOT Analysis, Karl Storz 180
Figure 5-16: SWOT Analysis, LABORIE 181
Figure 5-17: SWOT Analysis, Lumenis 182
Figure 5-18: SWOT Analysis, Olympus 183
Figure 5-19: SWOT Analysis, Teleflex 184
Figure 7-1: Urological Procedures by Segment, Europe, 2018 – 2028 197
Figure 7-2: Urological Procedures by Country, Europe, 2018 – 2028 198
Figure 7-3: Prostate Cancer Procedures by Type, Europe, 2018 – 2028 (1 of 2) 201
Figure 7-4: Prostate Cancer Procedures by Type, Europe, 2018 – 2028 (2 of 2) 202
Figure 7-5: Total Prostate Cancer Procedures by Country, Europe, 2018 – 2028 203
Figure 7-6: Open and Laparoscopic Prostatectomy Procedures by Country, Europe, 2018 – 2028 204
Figure 7-7: Robotic Prostatectomy Procedures by Country, Europe, 2018 – 2028 205
Figure 7-8: Watchful Waiting Procedures by Country, Europe, 2018 – 2028 206
Figure 7-9: HIFU Procedures by Country, Europe, 2018 – 2028 207
Figure 7-10: Brachytherapy Procedures by Country, Europe, 2018 – 2028 208
Figure 7-11: High Dose Radiation Procedures by Country, Europe, 2018 – 2028 209
Figure 7-12: External Radiation Therapy (Primary) Procedures by Country, Europe, 2018 – 2028 210
Figure 7-13: External Radiation Therapy (Secondary) Procedures by Country, Europe, 2018 – 2028 211
Figure 7-14: Interventional BPH Procedures by Type, Europe, 2018 – 2028yeah no 213
Figure 7-15: Total Interventional BPH Procedures by Country, Europe, 2018 – 2028 214
Figure 7-16: TURP Procedures by Country, Europe, 2018 – 2028 215
Figure 7-17: Laser BPH Procedures by Country, Europe, 2018 – 2028 216
Figure 7-18: Stone Management Procedures by Type, Europe, 2015 – 2025 218
Figure 7-19: Total Stone Management Procedures by Country, Europe, 2018 – 2028 219
Figure 7-20: ESWL Procedures by Country, Europe, 2018 – 2028 220
Figure 7-21: Stone Management Holmium Laser Procedures by Country, Europe, 2018 – 2028 221
Figure 7-22: PCNL Procedures by Country, Europe, 2018 – 2028 222
Figure 7-23: Ureteral Stent Placement Procedures by Country, Europe, 2018 – 2028 223
Figure 7-24: Nephrostomy Procedures by Country, Europe, 2018 – 2028 225
Figure 7-25: Urinary Incontinence Procedures by Type, Europe, 2018 – 2028 227
Figure 7-26: Total Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 228
Figure 7-27: Male Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 229
Figure 7-28: Female Urinary Incontinence Procedures by Country, Europe, 2018 – 2028 230
Figure 7-29: Erectile Dysfunction Procedures by Country, Europe, 2018 – 2028 232
Figure 7-30: Inflatable Implant Procedures by Country, Europe, 2018 – 2028 233
Figure 7-31: Malleable Implant Procedures by Country, Europe, 2018 – 2028 234
Figure 8-1: Urinary Catheter Market by Segment, Europe, 2018 – 2028 (€M) 237
Figure 8-2: Urinary Catheter Market by Segment, Europe, 2018 – 2028 (US$M) 238
Figure 8-3: Total Urinary Catheter Market, Europe, 2018 – 2028 240
Figure 8-4: Units Sold by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (1 of 2) 241
Figure 8-5: Units Sold by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (2 of 2) 242
Figure 8-6: Average Selling Price by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (€) 243
Figure 8-7: Average Selling Price by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (US$) 244
Figure 8-8: Market Value by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (€M) 245
Figure 8-9: Market Value by Country, Total Urinary Catheter Market, Europe, 2018 – 2028 (US$M) 246
Figure 8-10: Intermittent Catheter Market, Europe, 2018 – 2028 248
Figure 8-11: Units Sold by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (1 of 2) 249
Figure 8-12: Units Sold by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (2 of 2) 250
Figure 8-13: Average Selling Price by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (€) 251
Figure 8-14: Average Selling Price by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (US$) 252
Figure 8-15: Market Value by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (€M) 253
Figure 8-16: Market Value by Country, Intermittent Catheter Market, Europe, 2018 – 2028 (US$M) 254
Figure 8-17: Foley Catheter Market, Europe, 2018 – 2028 256
Figure 8-18: Units Sold by Country, Foley Catheter Market, Europe, 2018 – 2028 (1 of 2) 257
Figure 8-19: Units Sold by Country, Foley Catheter Market, Europe, 2018 – 2028 (2 of 2) 258
Figure 8-20: Average Selling Price by Country, Foley Catheter Market, Europe, 2018 – 2028 (€) 259
Figure 8-21: Average Selling Price by Country, Foley Catheter Market, Europe, 2018 – 2028 (US$) 260
Figure 8-22: Market Value by Country, Foley Catheter Market, Europe, 2018 – 2028 (€M) 261
Figure 8-23: Market Value by Country, Foley Catheter Market, Europe, 2018 – 2028 (US$M) 262
Figure 8-24: External Catheter Market by Segment, Europe, 2018 – 2028 (€M) 263
Figure 8-25: External Catheter Market by Segment, Europe, 2018 – 2028 (US$M) 264
Figure 8-26: Total External Catheter Market, Europe, 2018 – 2028 265
Figure 8-27: Male External Catheter Market, Europe, 2018 – 2028 267
Figure 8-28: Units Sold by Country, Male External Catheter Market, Europe, 2018 – 2028 268
Figure 8-29: Average Selling Price by Country, Male External Catheter Market, Europe, 2018 – 2028 (€) 269
Figure 8-30: Average Selling Price by Country, Male External Catheter Market, Europe, 2018 – 2028 (US$) 270
Figure 8-31: Market Value by Country, Male External Catheter Market, Europe, 2018 – 2028 (€M) 271
Figure 8-32: Market Value by Country, Male External Catheter Market, Europe, 2018 – 2028 (US$M) 272
Figure 8-33: Female External Catheter Market, Europe, 2018 – 2028 273
Figure 8-34: Leading Competitors, Urinary Catheter Market, Europe, 2021 279
Figure 9-1: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028 (€M) 284
Figure 9-2: Urinary Incontinence Device Market by Segment, Europe, 2018 – 2028 (US$M) 284
Figure 9-3: Urethral Bulking Agent Market, Europe, 2018 – 2028 287
Figure 9-4: Urinary Incontinence Sling Market by Segment, Europe, 2018 – 2028 (€M) 288
Figure 9-5: Urinary Incontinence Sling Market by Segment, Europe, 2018 – 2028 (US$M) 289
Figure 9-6: Total Urinary Incontinence Sling Market, Europe, 2018 – 2028 290
Figure 9-7: Units Sold by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 291
Figure 9-8: Average Selling Price by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (€) 292
Figure 9-9: Average Selling Price by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (US$) 293
Figure 9-10: Market Value by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (€M) 294
Figure 9-11: Market Value by Country, Total Incontinence Management Device Market, Europe, 2018 – 2028 (US$M) 295
Figure 9-12: Female Incontinence Sling Market by Segment, Europe, 2018 – 2028 (€M) 297
Figure 9-13: Female Incontinence Sling Market by Segment, Europe, 2018 – 2028 (US$M) 298
Figure 9-14: Total Female Incontinence Sling Market, Europe, 2018 – 2028 299
Figure 9-15: Units Sold by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 300
Figure 9-16: Average Selling Price by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (€) 301
Figure 9-17: Average Selling Price by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (US$) 302
Figure 9-18: Market Value by Country, Total Female Incontinence Sling Market, Europe, 2018 – 2028 (€M) 303
Figure 9-19: Market Value by Country, Total Female Incontinence Sling Marke

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us